STOCK TITAN

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

electroCore (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced its participation in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21, 2024 in New York City. Joshua Lev, Chief Financial Officer, will be available for one-on-one meetings throughout the event. Interested investors can arrange meetings through their Canaccord Genuity representatives.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+1.49% News Effect

On the day this news was published, ECOR gained 1.49%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

ROCKAWAY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum taking place in New York City on November 21, 2024.

Joshua Lev, Chief Financial Officer, will host one-on-one meetings throughout the day.

To schedule a one-on-one meeting with Mr. Lev, investors are encouraged to reach out to their CG representative. For more information regarding the event please visit https://www.meetmax.com/sched/event_110807/conference_home.html.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.

For more information, visit www.electrocore.com.

Contact

ECOR Investor Relations
(973) 302-9253
investors@electrocore.com


FAQ

When is electroCore (ECOR) participating in the Canaccord Genuity MedTech Forum?

electroCore will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21, 2024, in New York City.

Who will represent electroCore (ECOR) at the Canaccord Genuity Forum?

Joshua Lev, Chief Financial Officer of electroCore, will represent the company and host one-on-one meetings throughout the day.

How can investors schedule meetings with electroCore (ECOR) at the Canaccord Forum?

Investors can schedule one-on-one meetings with Joshua Lev by contacting their Canaccord Genuity representative.

Where will the Canaccord Genuity Forum featuring electroCore (ECOR) take place?

The forum will take place in New York City on November 21, 2024.
Electrocore

NASDAQ:ECOR

ECOR Rankings

ECOR Latest News

ECOR Latest SEC Filings

ECOR Stock Data

37.98M
5.14M
37.28%
15.51%
5.96%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
ROCKAWAY